SUVmax Determined Using PSMA PET/CT Is Associated With Oncological Outcomes in Patients With Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Standardised uptake values as determined on prostate-specific membrane antigen positron emission tomography/computed tomography is associated with oncological outcomes in patients with prostate cancer
BJU Int 2022 Jun 01;129(6)768-776, YJL Bodar, H Veerman, D Meijer, K de Bie, PJ van Leeuwen, ML Donswijk, RJA van Moorselaar, NH Hendrikse, R Boellaard, DE Oprea-Lager, AN VisFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.